Generic Drugs Regulations and Registration in Indonesia, Malaysia and Vietnam: A Drug Regulatory Case Study
Objectives:The present study describes the generic drug regulations and registration process in three ASEAN countries Indonesia, Malaysia and Vietnam. Methods:For the current study, the information has been taken from guidelines set forth by the respective regulatory authorities of three selected AS...
Saved in:
Published in | Journal of young pharmacists Vol. 14; no. 1; pp. 33 - 36 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
Bangalore
InPharm
01.01.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objectives:The present study describes the generic drug regulations and registration process in three ASEAN countries Indonesia, Malaysia and Vietnam. Methods:For the current study, the information has been taken from guidelines set forth by the respective regulatory authorities of three selected ASEAN countries concerning the technical guidelines available for generic drugs. Relevant data were also collected from regulatory websites and articles from reputed journals.Results:The process of site evaluation, pre-submission, dossier screening, registration and regulatory approval of generic drugs in Indonesia and Vietnam is quite similar concerning the regulations framed by their respective drug regulatory authorities. In Malaysia, Drug Control Authority accepts only web-based online submissions. The applicant for product registration must be registered with the Malaysian Register of Business (ROB) and should become a quest member at the NPCB website. Conclusion: From our studies relevant to the regulatory perspectives, it is concluded that Malaysia had well-framed drug regulations for generic drugs compared to Indonesia and Vietnam. |
---|---|
AbstractList | Objectives:The present study describes the generic drug regulations and registration process in three ASEAN countries Indonesia, Malaysia and Vietnam. Methods:For the current study, the information has been taken from guidelines set forth by the respective regulatory authorities of three selected ASEAN countries concerning the technical guidelines available for generic drugs. Relevant data were also collected from regulatory websites and articles from reputed journals.Results:The process of site evaluation, pre-submission, dossier screening, registration and regulatory approval of generic drugs in Indonesia and Vietnam is quite similar concerning the regulations framed by their respective drug regulatory authorities. In Malaysia, Drug Control Authority accepts only web-based online submissions. The applicant for product registration must be registered with the Malaysian Register of Business (ROB) and should become a quest member at the NPCB website. Conclusion: From our studies relevant to the regulatory perspectives, it is concluded that Malaysia had well-framed drug regulations for generic drugs compared to Indonesia and Vietnam. |
Author | CR, Sowmya DS, Sandeep V, Anoop Narayanan MP, Gowrav |
Author_xml | – sequence: 1 givenname: Sandeep surname: DS fullname: DS, Sandeep – sequence: 2 givenname: Sowmya surname: CR fullname: CR, Sowmya – sequence: 3 givenname: Anoop Narayanan surname: V fullname: V, Anoop Narayanan – sequence: 4 givenname: Gowrav surname: MP fullname: MP, Gowrav |
BookMark | eNo1kEtPwzAQhC1UJErpkbslriT4GcfcqgKlUhESr6u1xE6V0jrFTg759yQt3cvOrkbfSHOJRr72DqFrSlIpObnbdPuUEcZSKlJ1hsZEK5lQSeTopEXOL9A0xg0ZRhHF9Rj9LJx3oSrwQ2jXEb-5dbuFpqp9xODtcFexCYcPrjxeetvHxgpu8QtsoevVwfdVucbD7h7PDqATpw4dnkN0-L1pbXeFzkvYRjf93xP0-fT4MX9OVq-L5Xy2SgrGRZMAzSQrWO5UzhQlDjQHar9LKwrNc51xbnOpAYpMCF0IRWwpBVMcMsFlphSfoJsjdx_q39bFxmzqNvg-0nBKcpIrTVnvSo6uItQxBleafah2EDpDiRkqNX2lZqjUUGEU_wO0GGpx |
CitedBy_id | crossref_primary_10_22159_ijpps_2024v16i7_50699 |
ContentType | Journal Article |
Copyright | 2022. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2022. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION NAPCQ |
DOI | 10.5530/jyp.2022.14.7 |
DatabaseName | CrossRef Nursing & Allied Health Premium |
DatabaseTitle | CrossRef Nursing & Allied Health Premium |
DatabaseTitleList | Nursing & Allied Health Premium |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 0975-1505 |
EndPage | 36 |
ExternalDocumentID | 10_5530_jyp_2022_14_7 |
GeographicLocations | Vietnam Malaysia Indonesia |
GeographicLocations_xml | – name: Vietnam – name: Malaysia – name: Indonesia |
GroupedDBID | --- 0R~ 29L 2WC 3V. 53G 61Y 7RV 8FI 8G5 AAYXX ABDBF ABFRF ABUWG ADBBV AEFWE AEGXH AEKER AFKRA ALIPV ALMA_UNASSIGNED_HOLDINGS AZQEC BAWUL BENPR BKEYQ BPHCQ BVXVI CITATION DIK DWQXO E3Z EBD EOJEC ESX F5P FDB FNPLU FYUFA GNUQQ GUQSH IAO IEA IHR KQ8 M2O MK0 NAPCQ O-L O5R O5S O9- OBODZ OK1 P2P PQQKQ PROAC RPM TR2 TUS UKHRP UNMZH ZCN |
ID | FETCH-LOGICAL-c234t-a1652c28e782710ea93a1dbfd4c9389633d859aac6449c470df54273a64356773 |
ISSN | 0975-1483 |
IngestDate | Thu Oct 10 21:48:09 EDT 2024 Fri Aug 23 01:53:08 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c234t-a1652c28e782710ea93a1dbfd4c9389633d859aac6449c470df54273a64356773 |
OpenAccessLink | https://jyoungpharm.org/sites/default/files/tmp/JYoungPharm-14-1-33.pdf |
PQID | 3108087912 |
PQPubID | 226469 |
PageCount | 4 |
ParticipantIDs | proquest_journals_3108087912 crossref_primary_10_5530_jyp_2022_14_7 |
PublicationCentury | 2000 |
PublicationDate | 2022-01-01 |
PublicationDateYYYYMMDD | 2022-01-01 |
PublicationDate_xml | – month: 01 year: 2022 text: 2022-01-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Bangalore |
PublicationPlace_xml | – name: Bangalore |
PublicationTitle | Journal of young pharmacists |
PublicationYear | 2022 |
Publisher | InPharm |
Publisher_xml | – name: InPharm |
SSID | ssj0000070739 |
Score | 2.2648532 |
Snippet | Objectives:The present study describes the generic drug regulations and registration process in three ASEAN countries Indonesia, Malaysia and Vietnam.... |
SourceID | proquest crossref |
SourceType | Aggregation Database |
StartPage | 33 |
SubjectTerms | Generic drugs Registration Regulatory approval |
Title | Generic Drugs Regulations and Registration in Indonesia, Malaysia and Vietnam: A Drug Regulatory Case Study |
URI | https://www.proquest.com/docview/3108087912 |
Volume | 14 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELdK98IL4lNsbMgPqC9tRpPY-dhbt67a0FYqLUV9ixw7qSogrdqUEf56znY-B0LASxS5lX3y_XL--Xx3RuidSMwhtzgxYj_yDGIOhRERUxgJ8YQYco-7yqd7O3Wu5uTDgi46ne-NqKV9Fp3yH7_NK_kfrUIb6FVmyf6DZqtOoQHeQb_wBA3D8690rGpGr3h_vN0vZb7Hcl9Gtum0w2VVFVe6Na7lxR3xTkfH3rIvDDSkMrL6n1ZxljLtsledlX3JA_gLWOdUuGHrALhBZHNpMPobXQMbRqxY-p10UMfqArxx7WK9W99_zZUMjWjFKduynBV3JY_S9XpTBQat77fsmxK5yEUrfBSW9cBHcZ3OpAxN56NLDdiIadMWN9rokLZsM_kFg9rQ6uoZD-2_vANJ2v9cViK1LFgGTt16oSsP96cfw8n85iYMLhfBI3RguT6lXXQwOh-fTyr_nKqDZOtSjYWwukSrHON9a4Q2pWmv6IqmBE_Rk0IteKTB8gx14vQ56s20cvIBDup8u90A9_CsLl2ev0CfC0RhhSjcQBQGXeImovAqxRWiBrjEk_pfgaczPFId4RpNWKIJKzS9RPPJZXBxZRTXcRjcsklmMNOhFre8GEgl8NKY-TYzRZQIwn2gvY5tC4_6jHGg2D4n7lAklAA7ZkB6qeO69ivUTUGq1wgL4jNBqKC2Sk9yJGlOEtiK2ITYkW8eol45o-FGV10JYbcqpz6EqQ_l1MOmNXQP0XE532HxYe5CW8bNeq5vWkd__vkNelyj9Rh1s-0-PgGOmUVvCzj8BKTnfXU |
link.rule.ids | 315,786,790,27955,27956 |
linkProvider | EBSCOhost |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Generic+Drugs+Regulations+and+Registration+in+Indonesia%2C+Malaysia+and+Vietnam%3A+A+Drug+Regulatory+Case+Study&rft.jtitle=Journal+of+young+pharmacists&rft.au=Sandeep%2C+D+S&rft.au=Sowmya%2C+C+R&rft.au=Narayanan%2C+Anoop&rft.au=Gowrav%2C+M+P&rft.date=2022-01-01&rft.pub=InPharm&rft.issn=0975-1483&rft.eissn=0975-1505&rft.volume=14&rft.issue=1&rft.spage=33&rft_id=info:doi/10.5530%2Fjyp.2022.14.7&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0975-1483&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0975-1483&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0975-1483&client=summon |